Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download report

Why Sano: Driving scientific innovation and business value in 2025

Genomics and precision medicine are advancing rapidly, with new therapies, technologies, and AI breakthroughs accelerating progress. Yet critical bottlenecks in infrastructure, expertise, workflows, and trial diversity continue to slow translation from science to patient impact. Sano helps sponsors address those barriers and make precision medicine trials faster, more inclusive, and more cost-effective.

This report highlights the successes driving the field forward, the bottlenecks still holding it back, and how Sano’s approach is helping sponsors overcome these challenges.

Download now to access the full report.

Group 6